Second monoclinic polymorph of 4-[(1H-benzimidazol-1-yl)methyl]benzoic acid

被引：1

作者：

Kuai, Hai-Wei ^{[1
]}

Cheng, Xiao-Chun ^{[1
]}

机构：

[1] Huaiyin Inst Technol, Fac Life Sci & Chem Engn, Huaian 223003, Peoples R China

来源：

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2011年 / 67卷

关键词：

data-to-parameter ratio = 14.3; mean σ(C-C) = 0.005 Å; R factor = 0.055; single-crystal X-ray study; T = 293 K; wR factor = 0.094;

D O I：

10.1107/S1600536811045983

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

Recently, we reported the first monoclinic [Kuai & Cheng (2011). Acta Cryst., E67, o2787] and the orthorhombic polymorph [Kuai & Cheng (2011). Acta Cryst., E67, o3014] of the title compound, C(15)H(12)N(2)O(2). Another monoclinic polymorph was obtained accidentally by the hydrothermal reaction of the title compound with manganese chloride in the presence of potassium hydroxide at 413 K. The asymmetric unit consists of four independent molecules. In the crystal, O-H center dot center dot center dot N hydrogen bonds link the independent molecules into four separate chains parallel to the b axis.

引用

页码：O3208 / U169

页数：16

共 50 条

[41] The 4-(Tris(4-methyl-1H-pyrazol-1-yl)methyl)aniline
Garrison, Bradley B.
Duhamel, Joseph E.
Antoine, Nehemiah
Symes, Steven J. K.
Grice, Kyle A.
McMillen, Colin D.
Pienkos, Jared A.
MOLBANK, 2024, 2024 (02)
[42] A monoclinic polymorph of 4-(2H-1,3-benzodioxol-5-yl)-1-(4-methylphenyl)-1H-pyrazol-5-amine
Jotani, Mukesh M.
Gajera, Nilesh N.
Patel, Mukesh C.
Sung, Herman H. Y.
Tiekink, Edward R. T.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 : 1121 - +
[43] Synthesis and exploration of QSAR model of 2-methyl-3-[2-(2-methylprop-1-en-1-yl)-1H-benzimidazol-1-yl] pyrimido[1,2-a] benzimidazol-4(3H)-one as potential antibacterial agents
Sharma, Pratibha
Kumar, Ashok
Sharma, Manisha
Singh, Jitendra
Bandyopadhyay, Prabal
Sathe, Manisha
Kaushik, M. P.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (02) : 294 - 301
[44] 2-({4-[ 4-(1H-Benzimidazol-2-yl) phenyl]1H-1,2,3-triazol-1-yl} methoxy) ethanol
Ouahrouch, Abdelaaziz
Taourirte, Moha
Lazrek, Hassan B.
Bats, Jan W.
Engels, Joachim W.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1908 - +
[45] COBALT(II) AND IRON(III) COMPLEXES WITH THE SCHIFF-BASES - 4-[[[2-(1H-BENZIMIDAZOL-2-YL)PHENYL]IMINO]METHYL]PHENOL AND 4-[(1H-BENZIMIDAZOL-2-YLIMINO)METHYL]PHENOL
MOLLEDA, C
MASAGUER, JR
GARCIAVAZQUEZ, JA
SYNTHESIS AND REACTIVITY IN INORGANIC AND METAL-ORGANIC CHEMISTRY, 1989, 19 (02): : 181 - 194
[46] 1-Methyl-2-({[(1-methyl-1H-benzimidazol-2-yl)methyl](phenyl)amino}methyl)1H-benzimidazol-3-ium picrate
Liu, Bin
Kou, Fan
Jia, Fei
Yuan, Jingkui
Wu, Huilu
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1816 - U1781
[47] Some 2-[4-(1H-benzimidazol-1-yl) phenyl]-1H-benzimidazole derivatives overcome imatinib resistance by induction of apoptosis and reduction of P-glycoprotein activity
Hekmatshoar, Yalda
Ozkan, Tulin
Alp, Mehmet
Gurkan-Alp, A. Selen
Sunguroglu, Asuman
CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (06) : 1521 - 1533
[48] 2-(1H-Benzimidazol-1-yl)-1-(2-furyl)ethanone O-propyloxime
Guven, Ozden Ozel
Erdogan, Taner
Coles, Simon J.
Hokelek, Tuncer
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : 01517 - U1962
[49] 4-(1H-Benzimidazol-3-ium-2-yl)-benzoate dihydrate
Jian, FF
Bei, FL
Yang, XJ
Lu, LD
Wang, X
Razak, IA
Raj, SSS
Fun, HK
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2001, 57 (02) : 176 - 177
[50] 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2- yl)-2-propyl-1H-1,3-benzodiazol-1-yl] methyl} phenyl) benzoic acid as green corrosion inhibitor for mild steel in 1 M hydrochloric acid
Verma, Chandrabhan
Quraishi, M. A.
Gupta, Neeraj Kumar
AIN SHAMS ENGINEERING JOURNAL, 2018, 9 (04) : 1225 - 1233

← 1 2 3 4 5 →